Partner
Daniel Chai
Managing Partner, Turret Capital Management
- Firm
- Turret Capital Management
- Title
- Managing Partner
- Role
- Managing partner
- Known as
- Investor
Record updated 4 October 2026
About
Daniel J. Chai, M.D. is the Founder and Managing Partner of Turret Capital Management, a healthcare venture building and investment firm based in New York. Dr. Chai has over 20 years of experience as an investor and healthcare entrepreneur. Prior to forming Turret Capital in 2016, Daniel was a Portfolio Manager at several leading hedge funds and investment firms including Citadel, UBS and Neuberger Berman. Dr. Chai was an early investor and board member of Nexgen Spine (acquired by Stryker Corporation), a co-founder of Serenikey Therapeutics (now Terran BioSciences), and a board member of TeraImmune Inc. (acquired by Baudax Bio). Daniel graduated as an Angell Scholar from the University of Michigan and received his B.S. degree with Honors. He received his M.D. degree from Columbia University’s College of Physician & Surgeons.
Is this you? Remove my profile